25 XP   0   0   10

Henan Taloph Pharmaceutical Stock Co Ltd
Buy, Hold or Sell?

Let's analyse Taloph together

PenkeI guess you are interested in Henan Taloph Pharmaceutical Stock Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Henan Taloph Pharmaceutical Stock Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Henan Taloph Pharmaceutical Stock Co Ltd

I send you an email if I find something interesting about Henan Taloph Pharmaceutical Stock Co Ltd.

Quick analysis of Taloph (30 sec.)










What can you expect buying and holding a share of Taloph? (30 sec.)

How much money do you get?

How much money do you get?
¥0.05
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥2.83
Expected worth in 1 year
¥2.89
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
¥0.41
Return On Investment
7.9%

For what price can you sell your share?

Current Price per Share
¥5.24
Expected price per share
¥3.75 - ¥5.75
How sure are you?
50%

1. Valuation of Taloph (5 min.)




Live pricePrice per Share (EOD)

¥5.24

Intrinsic Value Per Share

¥-1.23 - ¥-0.17

Total Value Per Share

¥1.60 - ¥2.66

2. Growth of Taloph (5 min.)




Is Taloph growing?

Current yearPrevious yearGrowGrow %
How rich?$224.1m$222.8m$1.2m0.6%

How much money is Taloph making?

Current yearPrevious yearGrowGrow %
Making money$6m-$9.9m$15.9m265.6%
Net Profit Margin2.1%-3.7%--

How much money comes from the company's main activities?

3. Financial Health of Taloph (5 min.)




What can you expect buying and holding a share of Taloph? (5 min.)

Welcome investor! Taloph's management wants to use your money to grow the business. In return you get a share of Taloph.

What can you expect buying and holding a share of Taloph?

First you should know what it really means to hold a share of Taloph. And how you can make/lose money.

Speculation

The Price per Share of Taloph is ¥5.24. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Taloph.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Taloph, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥2.83. Based on the TTM, the Book Value Change Per Share is ¥0.02 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.29 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.09 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Taloph.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.2%0.010.2%-0.02-0.3%0.000.0%0.000.0%
Usd Book Value Change Per Share0.000.0%0.000.0%-0.04-0.8%0.010.2%0.010.2%
Usd Dividend Per Share0.010.2%0.010.2%0.020.3%0.020.3%0.020.3%
Usd Total Gains Per Share0.010.3%0.010.3%-0.02-0.5%0.030.5%0.030.5%
Usd Price Per Share0.85-0.85-0.88-0.86-0.89-
Price to Earnings Ratio80.77-80.77--50.67-209.41-392.27-
Price-to-Total Gains Ratio59.11-59.11--36.53--18.15-4.58-
Price to Book Ratio2.17-2.17-2.26-2.24-2.49-
Price-to-Total Gains Ratio59.11-59.11--36.53--18.15-4.58-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.723644
Number of shares1381
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.02
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.010.03
Gains per Quarter (1381 shares)19.7836.98
Gains per Year (1381 shares)79.12147.93
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16712698662138
213325148172123286
320037227259185434
426750306345247582
533362385431309730
640075464517370878
7467875436034321026
8534996226904941174
96001127017765561322
106671247808626171470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%22.02.00.091.7%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%21.03.00.087.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.01.095.8%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%21.03.00.087.5%

Fundamentals of Taloph

About Henan Taloph Pharmaceutical Stock Co Ltd

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of Chinese medicines in China. The company primarily offers its products in the forms of oral liquids, tablets, capsules, fluids, and others. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, Danshen oral liquid, Xiaoer Qingre Zhike oral liquid, pediatric compound Ji Neijin chewable tablets, and Huperzine A tablets. The company serves hospitals, primary medical institutions, and retail terminals. The company was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. The company was founded in 1993 and is based in Zhengzhou, China.

Fundamental data was last updated by Penke on 2024-04-17 06:08:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Henan Taloph Pharmaceutical Stock Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Taloph earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Taloph to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 2.1% means that ¥0.02 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 2.1%. The company is making a profit. +1
  • The TTM is 2.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.1%TTM2.1%0.0%
TTM2.1%YOY-3.7%+5.8%
TTM2.1%5Y0.9%+1.2%
5Y0.9%10Y-0.1%+1.0%
1.1.2. Return on Assets

Shows how efficient Taloph is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Taloph to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.2% Return on Assets means that Taloph generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 1.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.2%TTM1.2%0.0%
TTM1.2%YOY-2.0%+3.2%
TTM1.2%5Y0.4%+0.8%
5Y0.4%10Y0.0%+0.4%
1.1.3. Return on Equity

Shows how efficient Taloph is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Taloph to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.8% Return on Equity means Taloph generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 2.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.8%TTM2.8%0.0%
TTM2.8%YOY-4.6%+7.4%
TTM2.8%5Y0.8%+2.0%
5Y0.8%10Y0.0%+0.8%

1.2. Operating Efficiency of Henan Taloph Pharmaceutical Stock Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Taloph is operating .

  • Measures how much profit Taloph makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Taloph to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y4.4%-4.4%
5Y4.4%10Y5.2%-0.8%
1.2.2. Operating Ratio

Measures how efficient Taloph is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.68 means that the operating costs are ¥1.68 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 1.676. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.676. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.676TTM1.6760.000
TTM1.676YOY1.737-0.062
TTM1.6765Y1.642+0.034
5Y1.64210Y1.551+0.091

1.3. Liquidity of Henan Taloph Pharmaceutical Stock Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Taloph is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.21 means the company has ¥1.21 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 1.208. The company is just able to pay all its short-term debts.
  • The TTM is 1.208. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.208TTM1.2080.000
TTM1.208YOY1.177+0.031
TTM1.2085Y1.330-0.122
5Y1.33010Y1.371-0.041
1.3.2. Quick Ratio

Measures if Taloph is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Taloph to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.54 means the company can pay off ¥0.54 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 0.541. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.541. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.541TTM0.5410.000
TTM0.541YOY0.454+0.087
TTM0.5415Y0.595-0.054
5Y0.59510Y0.631-0.036

1.4. Solvency of Henan Taloph Pharmaceutical Stock Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Taloph assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Taloph to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.55 means that Taloph assets are financed with 54.6% credit (debt) and the remaining percentage (100% - 54.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 0.546. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.546. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.546TTM0.5460.000
TTM0.546YOY0.552-0.006
TTM0.5465Y0.540+0.006
5Y0.54010Y0.502+0.038
1.4.2. Debt to Equity Ratio

Measures if Taloph is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Taloph to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 123.8% means that company has ¥1.24 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The MRQ is 1.238. The company is able to pay all its debts with equity. +1
  • The TTM is 1.238. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.238TTM1.2380.000
TTM1.238YOY1.269-0.031
TTM1.2385Y1.217+0.021
5Y1.21710Y1.058+0.159

2. Market Valuation of Henan Taloph Pharmaceutical Stock Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Taloph generates.

  • Above 15 is considered overpriced but always compare Taloph to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 80.77 means the investor is paying ¥80.77 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The EOD is 69.040. Based on the earnings, the company is expensive. -2
  • The MRQ is 80.766. Based on the earnings, the company is expensive. -2
  • The TTM is 80.766. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD69.040MRQ80.766-11.726
MRQ80.766TTM80.7660.000
TTM80.766YOY-50.674+131.441
TTM80.7665Y209.409-128.643
5Y209.40910Y392.275-182.865
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The EOD is 4,975.946. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 5,821.097. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 5,821.097. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD4,975.946MRQ5,821.097-845.151
MRQ5,821.097TTM5,821.0970.000
TTM5,821.097YOY-19.137+5,840.234
TTM5,821.0975Y1,911.258+3,909.839
5Y1,911.25810Y953.913+957.346
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Taloph is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Henan Taloph Pharmaceutical Stock Co Ltd:

  • The EOD is 1.852. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.167. Based on the equity, the company is underpriced. +1
  • The TTM is 2.167. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.852MRQ2.167-0.315
MRQ2.167TTM2.1670.000
TTM2.167YOY2.265-0.098
TTM2.1675Y2.242-0.075
5Y2.24210Y2.489-0.248
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Henan Taloph Pharmaceutical Stock Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0160.0160%-0.285+1850%0.081-80%0.093-82%
Book Value Per Share--2.8292.8290%2.812+1%2.738+3%2.604+9%
Current Ratio--1.2081.2080%1.177+3%1.330-9%1.371-12%
Debt To Asset Ratio--0.5460.5460%0.552-1%0.540+1%0.502+9%
Debt To Equity Ratio--1.2381.2380%1.269-2%1.217+2%1.058+17%
Dividend Per Share--0.0870.0870%0.111-21%0.113-23%0.109-20%
Eps--0.0760.0760%-0.126+266%0.018+326%-0.003+104%
Free Cash Flow Per Share--0.0010.0010%-0.333+31710%-0.067+6489%-0.019+1904%
Free Cash Flow To Equity Per Share--0.0010.0010%-0.333+31710%-0.114+10956%0.023-95%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.166--------
Intrinsic Value_10Y_min---1.231--------
Intrinsic Value_1Y_max---0.019--------
Intrinsic Value_1Y_min---0.088--------
Intrinsic Value_3Y_max---0.054--------
Intrinsic Value_3Y_min---0.297--------
Intrinsic Value_5Y_max---0.088--------
Intrinsic Value_5Y_min---0.540--------
Market Cap3007162723.840-17%3517922914.7903517922914.7900%3655655622.710-4%3564981589.996-1%3713043585.646-5%
Net Profit Margin--0.0210.0210%-0.037+275%0.009+142%-0.001+106%
Operating Margin----0%-0%0.044-100%0.052-100%
Operating Ratio--1.6761.6760%1.737-4%1.642+2%1.551+8%
Pb Ratio1.852-17%2.1672.1670%2.265-4%2.242-3%2.489-13%
Pe Ratio69.040-17%80.76680.7660%-50.674+163%209.409-61%392.275-79%
Price Per Share5.240-17%6.1306.1300%6.370-4%6.212-1%6.470-5%
Price To Free Cash Flow Ratio4975.946-17%5821.0975821.0970%-19.137+100%1911.258+205%953.913+510%
Price To Total Gains Ratio50.526-17%59.10859.1080%-36.525+162%-18.154+131%4.585+1189%
Quick Ratio--0.5410.5410%0.454+19%0.595-9%0.631-14%
Return On Assets--0.0120.0120%-0.020+264%0.004+219%0.000+102%
Return On Equity--0.0280.0280%-0.046+266%0.008+242%0.000+101%
Total Gains Per Share--0.1040.1040%-0.174+268%0.194-47%0.201-48%
Usd Book Value--224189954.200224189954.2000%222898895.283+1%217022441.182+3%206354687.838+9%
Usd Book Value Change Per Share--0.0020.0020%-0.039+1850%0.011-80%0.013-82%
Usd Book Value Per Share--0.3910.3910%0.388+1%0.378+3%0.360+9%
Usd Dividend Per Share--0.0120.0120%0.015-21%0.016-23%0.015-20%
Usd Eps--0.0100.0100%-0.017+266%0.002+326%0.000+104%
Usd Free Cash Flow--83459.37583459.3750%-26381113.477+31710%-5331872.677+6489%-1505358.125+1904%
Usd Free Cash Flow Per Share--0.0000.0000%-0.046+31710%-0.009+6489%-0.003+1904%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%-0.046+31710%-0.016+10956%0.003-95%
Usd Market Cap415289172.162-17%485825154.532485825154.5320%504846041.496-4%492323957.578-1%512771319.178-5%
Usd Price Per Share0.724-17%0.8470.8470%0.880-4%0.858-1%0.894-5%
Usd Profit--6015183.6926015183.6920%-9962563.635+266%1446311.250+316%-223982.372+104%
Usd Revenue--285854396.518285854396.5180%270771884.130+6%231014567.031+24%192488783.742+49%
Usd Total Gains Per Share--0.0140.0140%-0.024+268%0.027-47%0.028-48%
 EOD+4 -4MRQTTM+0 -0YOY+27 -75Y+19 -1610Y+17 -18

3.2. Fundamental Score

Let's check the fundamental score of Henan Taloph Pharmaceutical Stock Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1569.040
Price to Book Ratio (EOD)Between0-11.852
Net Profit Margin (MRQ)Greater than00.021
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.541
Current Ratio (MRQ)Greater than11.208
Debt to Asset Ratio (MRQ)Less than10.546
Debt to Equity Ratio (MRQ)Less than11.238
Return on Equity (MRQ)Greater than0.150.028
Return on Assets (MRQ)Greater than0.050.012
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Henan Taloph Pharmaceutical Stock Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.863
Ma 20Greater thanMa 505.134
Ma 50Greater thanMa 1005.103
Ma 100Greater thanMa 2005.436
OpenGreater thanClose5.080
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,576,855
Total Liabilities1,953,466
Total Stockholder Equity1,578,494
 As reported
Total Liabilities 1,953,466
Total Stockholder Equity+ 1,578,494
Total Assets = 3,576,855

Assets

Total Assets3,576,855
Total Current Assets1,993,074
Long-term Assets1,583,781
Total Current Assets
Cash And Cash Equivalents 196,666
Short-term Investments 153,300
Net Receivables 739,637
Inventory 455,500
Other Current Assets 16,353
Total Current Assets  (as reported)1,993,074
Total Current Assets  (calculated)1,561,455
+/- 431,619
Long-term Assets
Property Plant Equipment 529,652
Goodwill 286,493
Intangible Assets 77,197
Long-term Assets Other 48,088
Long-term Assets  (as reported)1,583,781
Long-term Assets  (calculated)941,430
+/- 642,352

Liabilities & Shareholders' Equity

Total Current Liabilities1,650,148
Long-term Liabilities303,318
Total Stockholder Equity1,578,494
Total Current Liabilities
Short Long Term Debt 381,838
Accounts payable 470,286
Other Current Liabilities 5,520
Total Current Liabilities  (as reported)1,650,148
Total Current Liabilities  (calculated)857,644
+/- 792,504
Long-term Liabilities
Long term Debt 183,800
Capital Lease Obligations Min Short Term Debt19,286
Long-term Liabilities Other 1,615
Long-term Liabilities  (as reported)303,318
Long-term Liabilities  (calculated)204,701
+/- 98,618
Total Stockholder Equity
Retained Earnings 230,105
Total Stockholder Equity (as reported)1,578,494
Total Stockholder Equity (calculated)230,105
+/- 1,348,389
Other
Capital Stock573,886
Common Stock Shares Outstanding 573,886
Net Debt 368,972
Net Invested Capital 2,144,132
Net Working Capital 342,925
Property Plant and Equipment Gross 529,652



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
566,837
622,909
692,995
708,968
739,113
750,660
809,289
844,861
936,401
1,092,164
1,251,240
1,460,168
1,569,436
1,953,624
2,291,707
2,639,558
2,650,827
2,808,177
2,835,342
2,739,423
3,389,395
3,783,772
3,606,600
3,576,855
3,576,8553,606,6003,783,7723,389,3952,739,4232,835,3422,808,1772,650,8272,639,5582,291,7071,953,6241,569,4361,460,1681,251,2401,092,164936,401844,861809,289750,660739,113708,968692,995622,909566,837
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,354,960
1,332,299
1,582,084
1,722,834
1,759,659
1,882,375
1,943,707
2,031,240
1,993,074
1,993,0742,031,2401,943,7071,882,3751,759,6591,722,8341,582,0841,332,2991,354,960000000000000000
       Cash And Cash Equivalents 
138,899
145,534
154,386
141,228
133,614
96,385
64,995
55,145
36,761
73,209
86,528
120,558
133,407
455,623
657,370
578,334
585,702
569,056
670,108
398,091
487,316
380,549
311,384
196,666
196,666311,384380,549487,316398,091670,108569,056585,702578,334657,370455,623133,407120,55886,52873,20936,76155,14564,99596,385133,614141,228154,386145,534138,899
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
61,000
60,000
0
100,000
115,500
176,400
207,460
285,667
74,956
153,300
153,30074,956285,667207,460176,400115,500100,000060,00061,00000000000000000
       Net Receivables 
111,652
124,402
179,481
221,986
226,205
173,384
206,617
207,500
197,692
253,798
326,900
376,029
431,222
551,892
511,592
473,283
451,939
579,142
568,149
811,971
487,991
520,771
709,294
739,637
739,637709,294520,771487,991811,971568,149579,142451,939473,283511,592551,892431,222376,029326,900253,798197,692207,500206,617173,384226,205221,986179,481124,402111,652
       Other Current Assets 
2,096
741
11,863
2,523
7,321
12,642
11,140
9,734
12,574
20,982
17,445
42,668
56,689
28,535
29,047
36,073
55,840
63,283
188,803
73,174
71,563
94,494
8,174
16,353
16,3538,17494,49471,56373,174188,80363,28355,84036,07329,04728,53556,68942,66817,44520,98212,5749,73411,14012,6427,3212,52311,8637412,096
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,318,528
1,226,093
1,112,509
1,012,596
1,507,020
1,840,065
1,575,359
1,583,781
1,583,7811,575,3591,840,0651,507,0201,012,5961,112,5091,226,0931,318,5280000000000000000
       Property Plant Equipment 
227,631
276,731
276,691
278,119
298,757
345,002
365,480
425,322
502,886
560,449
606,237
704,038
707,598
687,641
664,551
715,948
710,252
614,713
481,958
447,984
494,089
539,585
551,133
529,652
529,652551,133539,585494,089447,984481,958614,713710,252715,948664,551687,641707,598704,038606,237560,449502,886425,322365,480345,002298,757278,119276,691276,731227,631
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
891
286,391
287,334
286,527
286,493
286,493
286,493
286,493
286,493
286,493
286,493286,493286,493286,493286,493286,493286,527287,334286,39189100000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
75,682
120,181
120,048
139,775
0
0
0
0
0
00000139,775120,048120,18175,682000000000000000
       Intangible Assets 
15,774
16,158
16,628
16,024
15,419
883
17,741
15,699
14,242
12,296
10,363
9,828
7,831
12,184
84,151
104,674
159,055
156,207
133,094
81,442
76,862
72,840
76,059
77,197
77,19776,05972,84076,86281,442133,094156,207159,055104,67484,15112,1847,8319,82810,36312,29614,24215,69917,74188315,41916,02416,62816,15815,774
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,318,528
1,226,093
19,123
50,319
54,990
47,054
46,355
48,088
48,08846,35547,05454,99050,31919,1231,226,0931,318,5280000000000000000
> Total Liabilities 
162,449
206,073
264,700
268,357
283,437
278,696
322,243
323,294
381,430
506,123
641,917
831,281
912,934
861,222
1,105,550
1,140,159
1,150,861
1,299,932
1,444,138
1,427,621
1,858,824
2,006,136
1,992,560
1,953,466
1,953,4661,992,5602,006,1361,858,8241,427,6211,444,1381,299,9321,150,8611,140,1591,105,550861,222912,934831,281641,917506,123381,430323,294322,243278,696283,437268,357264,700206,073162,449
   > Total Current Liabilities 
159,009
206,073
263,800
268,357
283,437
278,696
322,243
323,294
381,430
483,353
579,148
597,227
649,982
657,274
960,075
1,037,142
582,273
707,742
1,404,118
959,090
1,503,881
1,649,676
1,726,028
1,650,148
1,650,1481,726,0281,649,6761,503,881959,0901,404,118707,742582,2731,037,142960,075657,274649,982597,227579,148483,353381,430323,294322,243278,696283,437268,357263,800206,073159,009
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
398,450
473,950
612,550
574,900
0
0
0
0
0000574,900612,550473,950398,4500000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
398,450
473,950
612,550
574,900
750,215
973,579
404,867
381,838
381,838404,867973,579750,215574,900612,550473,950398,4500000000000000000
       Accounts payable 
21,275
37,575
55,262
53,868
62,521
50,805
95,516
72,299
107,012
142,602
163,002
163,930
207,033
183,437
157,063
129,054
105,686
137,021
159,349
142,785
211,712
355,647
548,893
470,286
470,286548,893355,647211,712142,785159,349137,021105,686129,054157,063183,437207,033163,930163,002142,602107,01272,29995,51650,80562,52153,86855,26237,57521,275
       Other Current Liabilities 
56,334
36,898
41,938
37,089
43,706
55,991
37,327
41,595
44,418
59,751
63,146
54,497
115,149
67,387
89,858
59,310
62,218
75,780
70,987
187,045
115,185
139,261
10,000
5,520
5,52010,000139,261115,185187,04570,98775,78062,21859,31089,85867,387115,14954,49763,14659,75144,41841,59537,32755,99143,70637,08941,93836,89856,334
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
568,587
592,190
40,019
535,150
354,942
356,460
266,532
303,318
303,318266,532356,460354,942535,15040,019592,190568,5870000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-398,450
-473,950
-612,550
-574,900
33,812
23,555
28,810
19,286
19,28628,81023,55533,812-574,900-612,550-473,950-398,4500000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
566,000
1,702
40,000
532,200
130,000
131,615
1,615
1,615
1,6151,615131,615130,000532,20040,0001,702566,0000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
79,059
54,396
55,403
35,181
31,902
32,983
35,806
0
0
0035,80632,98331,90235,18155,40354,39679,059000000000000000
> Total Stockholder Equity
404,387
416,523
428,120
441,035
456,413
472,916
486,228
518,635
541,803
571,950
592,415
605,166
625,365
1,044,810
1,064,430
1,480,729
1,484,744
1,489,800
1,388,625
1,309,259
1,453,415
1,660,509
1,570,417
1,578,494
1,578,4941,570,4171,660,5091,453,4151,309,2591,388,6251,489,8001,484,7441,480,7291,064,4301,044,810625,365605,166592,415571,950541,803518,635486,228472,916456,413441,035428,120416,523404,387
   Common Stock
136,145
136,145
136,145
136,145
136,145
136,145
288,390
288,390
317,230
317,230
412,398
412,398
412,398
496,609
496,609
573,886
573,886
573,886
573,886
573,886
573,886
573,886
0
0
00573,886573,886573,886573,886573,886573,886573,886496,609496,609412,398412,398412,398317,230317,230288,390288,390136,145136,145136,145136,145136,145136,145
   Retained Earnings 
26,610
29,437
38,188
50,319
63,466
77,439
93,525
114,972
106,965
134,236
120,679
132,922
151,992
185,735
254,557
254,375
258,390
263,518
142,460
205,920
235,161
232,147
186,548
230,105
230,105186,548232,147235,161205,920142,460263,518258,390254,375254,557185,735151,992132,922120,679134,236106,965114,97293,52577,43963,46650,31938,18829,43726,610
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,500
0
154,697
315,038
0
0
00315,038154,697019,500000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,069,909
Cost of Revenue-1,505,186
Gross Profit564,722564,722
 
Operating Income (+$)
Gross Profit564,722
Operating Expense-1,963,502
Operating Income106,407-1,398,780
 
Operating Expense (+$)
Research Development127,714
Selling General Administrative244,256
Selling And Marketing Expenses0
Operating Expense1,963,502371,971
 
Net Interest Income (+$)
Interest Income2,169
Interest Expense-51,797
Other Finance Cost-3,905
Net Interest Income-53,533
 
Pretax Income (+$)
Operating Income106,407
Net Interest Income-53,533
Other Non-Operating Income Expenses0
Income Before Tax (EBT)42,962106,407
EBIT - interestExpense = -51,797
43,557
95,354
Interest Expense51,797
Earnings Before Interest and Taxes (EBIT)094,759
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax42,962
Tax Provision--1,867
Net Income From Continuing Ops44,82944,829
Net Income43,557
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net053,533
 

Technical Analysis of Taloph
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Taloph. The general trend of Taloph is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Taloph's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Henan Taloph Pharmaceutical Stock Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 5.1 < 5.69 < 5.75.

The bearish price targets are: 4.59 > 3.75.

Tweet this
Henan Taloph Pharmaceutical Stock Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Henan Taloph Pharmaceutical Stock Co Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Henan Taloph Pharmaceutical Stock Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Henan Taloph Pharmaceutical Stock Co Ltd. The current macd is -0.030835.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Taloph price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Taloph. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Taloph price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Henan Taloph Pharmaceutical Stock Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Henan Taloph Pharmaceutical Stock Co Ltd. The current adx is 17.28.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Taloph shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Henan Taloph Pharmaceutical Stock Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Henan Taloph Pharmaceutical Stock Co Ltd. The current sar is 4.59.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Henan Taloph Pharmaceutical Stock Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Henan Taloph Pharmaceutical Stock Co Ltd. The current rsi is 53.86. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Henan Taloph Pharmaceutical Stock Co Ltd Daily Relative Strength Index (RSI) ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Henan Taloph Pharmaceutical Stock Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Taloph price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Henan Taloph Pharmaceutical Stock Co Ltd Daily Stochastic Oscillator ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Henan Taloph Pharmaceutical Stock Co Ltd. The current cci is 23.82.

Henan Taloph Pharmaceutical Stock Co Ltd Daily Commodity Channel Index (CCI) ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Henan Taloph Pharmaceutical Stock Co Ltd. The current cmo is 14.98.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Henan Taloph Pharmaceutical Stock Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Henan Taloph Pharmaceutical Stock Co Ltd. The current willr is -43.96551724.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Taloph is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Henan Taloph Pharmaceutical Stock Co Ltd Daily Williams %R ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Henan Taloph Pharmaceutical Stock Co Ltd.

Henan Taloph Pharmaceutical Stock Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Henan Taloph Pharmaceutical Stock Co Ltd. The current atr is 0.23213286.

Henan Taloph Pharmaceutical Stock Co Ltd Daily Average True Range (ATR) ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Henan Taloph Pharmaceutical Stock Co Ltd. The current obv is 694,758,506.

Henan Taloph Pharmaceutical Stock Co Ltd Daily On-Balance Volume (OBV) ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Henan Taloph Pharmaceutical Stock Co Ltd. The current mfi is 46.78.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Henan Taloph Pharmaceutical Stock Co Ltd Daily Money Flow Index (MFI) ChartHenan Taloph Pharmaceutical Stock Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Henan Taloph Pharmaceutical Stock Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Henan Taloph Pharmaceutical Stock Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Henan Taloph Pharmaceutical Stock Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.863
Ma 20Greater thanMa 505.134
Ma 50Greater thanMa 1005.103
Ma 100Greater thanMa 2005.436
OpenGreater thanClose5.080
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Taloph with someone you think should read this too:
  • Are you bullish or bearish on Taloph? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Taloph? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Henan Taloph Pharmaceutical Stock Co Ltd

I send you an email if I find something interesting about Henan Taloph Pharmaceutical Stock Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Henan Taloph Pharmaceutical Stock Co Ltd.

Receive notifications about Henan Taloph Pharmaceutical Stock Co Ltd in your mailbox!